Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

231 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions
B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations
  • Stanford University Stanford, California, United States
  • Stanford, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT01691898

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver, Colorado, United States
  • Georgetown University Medical Center Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Completed

Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression

NCT03525665

Conditions
Disease Attributes, Disease Progression, Follicular Lymphoma, +13 more
Locations
  • U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT Trani, BT, Italy
  • Azienda Ospedaliera S. Gerardo Di Monza Monza, Monza Brianza, Italy
  • CROB Rionero in Vulture, Potenza, Italy
  • Università Cattolica del Sacro Cuore - Policlinico "A. Gemelli" Roma, RM, Italy
View all 27 locations
View Trial Details
Completed

Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma

NCT01493479

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Centre Hospitalier Universitaire de Lille Lille, France
  • Centre Hospitalier Universitaire de Nantes Nantes, France
  • Centre Henri Becquerel Rouen, France
  • St George's Hospital London, United Kingdom
View Trial Details
Completed

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

NCT00169208

Conditions
Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Service de médecine D - Maladies du Sang CHU Angers Angers, France
  • Service d'Hématologie Hôpital Jean Minjoz Besançon, France
  • Hôpital Henri Mondor Créteil, France
  • Hôpital A. Michallon BP 217X Grenoble, France
View all 16 locations
View Trial Details
Completed

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

NCT01282424

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • St. Jude Medical Center Fullerton, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Central Coast Medical Oncology Santa Maria, California, United States
View all 41 locations
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

NCT02401048

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Site-0397 Birmingham, Alabama, United States
  • Site-0047 Duarte, California, United States
  • Site-0038 Stanford, California, United States
  • Site-0388 Miami, Florida, United States
View Trial Details
Completed

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

NCT02213263

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • The Oncology Institute of Hope and Innovation Anaheim, California, United States
  • Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
View all 423 locations
View Trial Details

Related conditions